EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparative study on the analgesic effect of vortioxetine and other antidepressants in the streptozotocin mouse model of painful diabetic neuropathy

Serena Notartomaso iD, Roxana Paula Ginerete, Francesca Liberatore iD, Ferdinando Nicoletti, Valeria Bruno iD, Giuseppe Battaglia

Molecular Pain · 2025

DOI: 10.1177/17448069251367596 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Molecular Pain, 2025. Verfasst von Serena Notartomaso und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pathology, Neuropharmacology Unit, I.R.C.C.S. Neuromed, Pozzilli, Italy. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Antidepressive Agents, Analgesics, Diabetes Mellitus, Experimental. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Preclinical studies show that vortioxetine displays a robust analgesic activity in models of neuropathic pain. Here, we compared the effect of a 2-week treatment with vortioxetine, duloxetine, amitriptyline, fluoxetine, and paroxetine (all injected i.p. at the daily dose of 10 mg/kg) on mechanical and thermal pain thresholds, risk-taking behaviour and depressive-like behaviour in the streptozotocin (STZ) mouse model of painful diabetic neuropathy. Vortioxetine, duloxetine and amitriptyline reduced mechanical pain in diabetic mice, with vortioxetine displaying the greatest efficacy. In contrast, paroxetine and fluoxetine were inactive. Vortioxetine, duloxetine, amitriptyline and paroxetine were also effective in enhancing thermal pain thresholds in diabetic mice. Induction of diabetes did not affect risk-taking behaviour in the light-dark box test but enhanced depressive-like behaviour in the tail suspension test. All antidepressants, with the exception of amitriptyline, reversed depressive-like behaviour, whereas paroxetine unexpectedly reduced risk-taking behaviour in diabetic mice. We conclude that vortioxetine may offer therapeutic value for alleviating pain in diabetic neuropathy, particularly in patients with comorbid depression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NeuropathiesAntidepressive AgentsAnalgesicsDiabetes Mellitus, ExperimentalPiperazinesSulfidesAnimalsVortioxetineMaleMiceDisease Models, AnimalStreptozocinDepressionBehavior, AnimalDuloxetine HydrochloridePain Threshold

Stichwörter der Autor:innen

Antidepressantsdiabetic neuropathystreptozotocinvortioxetine

Substanzen

VortioxetineAntidepressive AgentsAnalgesicsPiperazinesSulfidesStreptozocinDuloxetine Hydrochloride

Autor:innen und Institutionen

  • Department of Molecular Pathology, Neuropharmacology Unit, I.R.C.C.S. Neuromed, Pozzilli, Italy.
  • Department of Physiology and Pharmacology, Sapienza University, Rome, Italy.

ORCID-Profile: Serena Notartomaso, Francesca Liberatore, Valeria Bruno

Zitieren

APA

Notartomaso, S., Ginerete, R. P., Liberatore, F., Nicoletti, F., Bruno, V., & Battaglia, G. (2025). Comparative study on the analgesic effect of vortioxetine and other antidepressants in the streptozotocin mouse model of painful diabetic neuropathy. Molecular Pain. https://doi.org/10.1177/17448069251367596

Vancouver

Notartomaso S, Ginerete RP, Liberatore F, Nicoletti F, Bruno V, Battaglia G. Comparative study on the analgesic effect of vortioxetine and other antidepressants in the streptozotocin mouse model of painful diabetic neuropathy. Molecular Pain. 2025. doi:10.1177/17448069251367596

BibTeX
@article{Notartomaso2025,
  author = {Notartomaso, Serena and Ginerete, Roxana Paula and Liberatore, Francesca and Nicoletti, Ferdinando and Bruno, Valeria and Battaglia, Giuseppe},
  title = {Comparative study on the analgesic effect of vortioxetine and other antidepressants in the streptozotocin mouse model of painful diabetic neuropathy},
  journal = {Molecular Pain},
  year = {2025},
  doi = {10.1177/17448069251367596}
}
Kostenlos starten →